This page is part of the PanCareSurPass Project HL7 FHIR Implementation Guide (v0.1.0: QA Preview) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Official URL: http://hl7.eu/fhir/ig/pcsp/ValueSet/vs-riskcondition-eu-pcsp | Version: 0.1.0 | |||
Active as of 2023-01-26 | Computable Name: RiskCondition |
Condition at risk proposed by the PCSP algorithm
References
http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp
This value set contains 47 concepts
Expansion based on PCSP Conditions at risk v0.1.0 (CodeSystem)
Code | System | Display | Definition |
1 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent thyroid cancer | Subsequent thyroid cancer |
2 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent breast cancer | Subsequent breast cancer |
3 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) |
4 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Impaired fertility Impaired spermatogenesis | Impaired fertility Impaired spermatogenesis |
5 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Testosterone deficiency | Testosterone deficiency |
6 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Physical sexual dysfunction | Physical sexual dysfunction |
7 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Premature ovarian insufficiency | Premature ovarian insufficiency |
8 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Ear problems | Ear problems |
9 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Impaired glucose metabolism and diabetes melitus | Impaired glucose metabolism and diabetes melitus |
10 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Dyslipidemia | Dyslipidemia |
11 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Overweight and obesity | Overweight and obesity |
12 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Hypertension | Hypertension |
13 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Reduced bone mineral density | Reduced bone mineral density |
14 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Osteonecrosis | Osteonecrosis |
15 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) | Hypothalamic-pituitary (HP) axis problems (High risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) |
16 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) | Hypothalamic-pituitary (HP) axis problems (Standard risk) Growth hormone deficiency (GHD) TSH deficiency (TSHD) LH/FSH deficiency (LH/FSHD) ACTH deficiency (ACTHD) |
17 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Central precocious puberty (CPP) For girls with age below 8 years | Central precocious puberty (CPP) For girls with age below 8 years |
18 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Central precocious puberty (CPP) For boys with age below 9 yearss | Central precocious puberty (CPP) For boys with age below 9 yearss |
19 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Thyroid function problems | Thyroid function problems |
20 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Cerebrovascular problem | Cerebrovascular problem |
21 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Neurocognitive problems | Neurocognitive problems |
22 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Peripheral neuropathy | Peripheral neuropathy |
23 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Cataract | Cataract |
24 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Eye problems | Eye problems |
25 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Craniofacial growth problems | Craniofacial growth problems |
26 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Spine scoliosis and kyphosis | Spine scoliosis and kyphosis |
27 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Lower urinary tract problems | Lower urinary tract problems |
28 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Obstetric problems | Obstetric problems |
29 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Dental and oral problems | Dental and oral problems |
30 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Gastro-intestinal problems | Gastro-intestinal problems |
31 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Arrhythmia | Arrhythmia |
32 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Pulmonary problems | Pulmonary problems |
33 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Renal problems (Glomerular dysfunction - Tubular dysfunction) | Renal problems (Glomerular dysfunction - Tubular dysfunction) |
34 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Liver problems | Liver problems |
35 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Iron overload | Iron overload |
36 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Spleen problems | Spleen problems |
37 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Tumor predisposition | Tumor predisposition |
38 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent melanoma and non-melanoma skin cancer | Subsequent melanoma and non-melanoma skin cancer |
39 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent colorectal cancer | Subsequent colorectal cancer |
40 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent Oral Cancer | Subsequent Oral Cancer |
41 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent acute myeloid leukaemia or myelodysplasia | Subsequent acute myeloid leukaemia or myelodysplasia |
42 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent bladder cancer | Subsequent bladder cancer |
43 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent Bone Cancer | Subsequent Bone Cancer |
44 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent lung cancer | Subsequent lung cancer |
45 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Subsequent CNS neoplasms | Subsequent CNS neoplasms |
46 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) | Cardiac problems (Cardiomyopathy and/or Valvular disease and/or Cardiac ischemia) |
47 | http://hl7.eu/fhir/ig/pcsp/CodeSystem/cs-riskcondition-eu-pcsp | Renal problems (Tubular dysfunction) | Renal problems (Tubular dysfunction) |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |